Dyadic Prices $2.9M Registered Direct Offering with Warrants at $0.795
DYAI sits 20% above its 52-week low of $0.655.
Summary
Dyadic International priced a $2.9 million registered direct offering at $0.795 per share with concurrent warrants, addressing its going concern cash crunch.
Key Events · Financing and Capital Events · DYAI
-
Registered Direct Offering Priced
3,625,000 shares offered at $0.795 per share for gross proceeds of $2,881,875.
-
Concurrent Warrant Placement
3,625,000 warrants issued at $0.005 each with exercise price of $0.84, adding potential future dilution.
-
Net Proceeds and Use
Net proceeds of approximately $2,280,143 after fees, intended for general corporate purposes including R&D and working capital.
-
Going Concern Context
Offering follows Q2 2026 10-Q disclosing going concern warning with cash reserves of $4.8 million.
Analysis · DYAI · Life Sciences
Dyadic International is raising $2.9 million in a registered direct offering priced at $0.795 per share, a slight discount to the last close of $0.88. The deal includes warrants for an additional 3.6 million shares at $0.84, creating potential future dilution. This capital raise comes just one day after the company reported a going concern warning with only $4.8 million in cash, making this financing critical for near-term survival. The offering is dilutive to existing shareholders but provides essential runway.
At the time of this filing, DYAI was trading at $0.79 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $28.1M. The 52-week trading range was $0.65 to $1.60. This filing was assessed with negative market sentiment and an importance score of 8 out of 10.